The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.
Open accessAbstract
Treatment of human fibroblast FS-4 cultures with human type II interferon preparations induced the synthesis of at least four proteins that were similar in size to four of the five proteins induced by type I interferons (Mr 120,000, 88,000, 67,000, and 56,000). However, the Mr 67,000 and 56,000 proteins were induced more strongly by type II than by type I interferon, and a counterpart of a Mr 80,000 protein induced by type I interferons was not noticeably induced by type II interferon preparations. We therefore compared type I and type II interferons for relative antiviral activities against different viruses (vesicular stomatitis, encephalomyocarditis, and vaccinia viruses and reovirus) and for cell growth-inhibitory activities on various cell types. The replication of vesicular stomatitis and encephalomyocarditis viruses was inhibited more strongly by type I interferon, whereas reovirus and vaccinia virus showed greater sensitivity to type II interferon preparations. This indicates that viruses may differ in their sensitivity to human type I and type II interferons and that the antiviral mechanisms induced by type I and type II interferons may have significant differences. The type I and type II interferons may have significant differences. The type I and type II interferons may also differ in their efficacies as antiproliferative agents. Type II interferon preparations at 2.5 units/ml inhibited the incorporatin of [3H]thymidine to a greater extent than did type I interferon at 400 units/ml. (For both type I and type II interferons, the unit of interferon activity was defined as the concentration that decreased the yield of vesicular stomatitis virus by 50% in FS-4 cultures.) Furthermore, whereas type II interferon preparations had a reversible cytostatic effect on normal human fibroblasts at 10 units/ml, the transformed cells tested (HeLa, osteosarcoma, U-amnion) showed extensive cell death, thus indicating that it may have a cytocidal effect on certain tumor cells. It appears that human type II interferon (or a factor present in these preparations) may be a potent antitumor agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Quantitative Film Detection of 3H and 14C in Polyacrylamide Gels by Fluorography
LASKEY, R. A., & MILLS, A. D. (1975) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1975.tb02238.x · Cited by 4,646
Procedures in Nucleic Acid Research.
Cohn, W. E. (1967) · Journal of the American Chemical Society · doi:10.1021/ja00985a054 · Cited by 2,026
A Restriction Point for Control of Normal Animal Cell Proliferation
Pardee, A. B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1286 · Cited by 1,415
Kerr, I. M., & Brown, R. E. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.256 · Cited by 787
Pardee, A. B., Dubrow, R., Hamlin, J. L., & Kletzien, R. F. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.003435 · Cited by 712
Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis
ROBERTS, W. K., HOVANESSIAN, A., BROWN, R. E., CLEMENS, M. J., & KERR, I. M. (1976) · Nature · doi:10.1038/264477a0 · Cited by 435
Antitumor effects of interferon
GRESSER, I., & TOVEY, M. (1978) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(78)90009-4 · Cited by 338
Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells
FARRELL, P. J., BROEZE, R. J., & LENGYEL, P. (1979) · Nature · doi:10.1038/279523a0 · Cited by 320
Interferon, double-stranded RNA, and protein phosphorylation.
Lebleu, B., Sen, G. C., Shaila, S., Cabrer, B., & Lengyel, P. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3107 · Cited by 319
Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA.
Farrell, P. J., Sen, G. C., Dubois, M. F., Ratner, L., Slattery, E., & Lengyel, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.12.5893 · Cited by 214
Zilberstein, A., Kimchi, A., Schmidt, A., & Revel, M. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.4734 · Cited by 189
Large-scale production and physicochemical characterization of human immune interferon
Langford, M. P., Georgiades, J. A., Stanton, G. J., DIANZANI, F., & Johnson, H. M. (1979) · Infection and Immunity · doi:10.1128/iai.26.1.36-41.1979 · Cited by 147
Interferons: Anti-neoplastic drugs?
Strander, H. A. (1977) · Annals of Hematology · doi:10.1007/bf00996140 · Cited by 133
Induction of 2′5′-oligoadenylate synthetase activity and a new protein by chick interferon
Ball, L. A. (1979) · Virology · doi:10.1016/0042-6822(79)90462-8 · Cited by 129
Interferon-induced proteins in human fibroblasts and development of the antiviral state
Rubin, B. Y., & Gupta, S. (1980) · Journal of Virology · doi:10.1128/jvi.34.2.446-454.1980 · Cited by 74
Self-citation
Cited by
Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962
Self-citationExpression of human immune interferon cDNA in E. coli and monkey cells
Gray, P. W., Leung, D. W., Pennica, D., Yelverton, E., Najarian, R., Simonsen, C. C., Derynck, R., Sherwood, P. J., Wallace, D. M., Berger, S. L., et al. (1982) · Nature · doi:10.1038/295503a0 · Cited by 689
Takikawa, O., Kuroiwa, T., Yamazaki, F., & Kido, R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77982-4 · Cited by 472
Williamson, B. D., Carswell, E. A., Rubin, B. Y., Prendergast, J. S., & Old, L. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5397 · Cited by 456
Self-citationPreferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells
Wallach, D., Fellous, M., & Revel, M. (1982) · Nature · doi:10.1038/299833a0 · Cited by 383
Metadata
- Authors
- Rubin, B. Y., & Gupta, S. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1980-10
- Volume
- 77
- Issue
- 10
- Pages
- 5928-5932
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2019150375
- Cited by
- 274
- References
- 17
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.